Cargando…

Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement

The effects of genetic variants on warfarin dosing vary among different ethnic groups, especially in the Chinese population. The objective of this study was to recruit patients through a rigorous experimental design and to perform a comprehensive screen to identify gene polymorphisms that may influe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Rui, Cao, Jian, Zhang, Qian, Shi, Xin-Miao, Pan, Xiao-Dong, Dong, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266160/
https://www.ncbi.nlm.nih.gov/pubmed/28079798
http://dx.doi.org/10.1097/MD.0000000000005658
_version_ 1782500418181398528
author Liu, Rui
Cao, Jian
Zhang, Qian
Shi, Xin-Miao
Pan, Xiao-Dong
Dong, Ran
author_facet Liu, Rui
Cao, Jian
Zhang, Qian
Shi, Xin-Miao
Pan, Xiao-Dong
Dong, Ran
author_sort Liu, Rui
collection PubMed
description The effects of genetic variants on warfarin dosing vary among different ethnic groups, especially in the Chinese population. The objective of this study was to recruit patients through a rigorous experimental design and to perform a comprehensive screen to identify gene polymorphisms that may influence warfarin dosing in northern Han Chinese patients with mechanical heart valve replacement. Consenting patients (n = 183) with a stable warfarin dose were included in this study. Ninety-six single nucleotide polymorphisms (SNPs) in 30 genes involved in warfarin pharmacological pathways were genotyped using the Illumina SNP GoldenGate Assay, and their associations with warfarin dosing were assessed using univariate regression analysis with post hoc comparison using least significant difference analysis. Multiple linear regression was performed by incorporating patients’ clinical and genetic data to create a new algorithm for warfarin dosing. From the 96 SNPs analyzed, VKORC1 rs9923231, CYP1A2 rs2069514, CYP3A4 rs28371759, and APOE rs7412 were associated with higher average warfarin maintenance doses, whereas CYP2C9 rs1057910, EPHX1 rs2260863, and CYP4F2 rs2189784 were associated with lower warfarin doses (P < 0.05). Multiple linear regression analysis could estimate 44.4% of warfarin dose variability consisting of, in decreasing order, VKORC1 rs9923231 (14.2%), CYP2C9∗3 (9.6%), body surface area (6.7%), CYP1A2 rs2069514 (3.7%), age (2.7%), CYP3A4 rs28371759 (2.5%), CYP4F2 rs2108622 (1.9%), APOE rs7412 (1.7%), and VKORC1 rs2884737 (1.4%). In the dosing algorithm we developed, we confirmed the strongest effects of VKORC1, CYP2C9 on warfarin dosing. In the limited sample set, we also found that novel genetic predictors (CYP1A2, CYP3A4, APOE, EPHX1, CYP4F2, and VKORC1 rs2884737) may be associated with warfarin dosing. Further validation is needed to assess our results in larger independent northern Chinese samples.
format Online
Article
Text
id pubmed-5266160
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52661602017-02-07 Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement Liu, Rui Cao, Jian Zhang, Qian Shi, Xin-Miao Pan, Xiao-Dong Dong, Ran Medicine (Baltimore) 3500 The effects of genetic variants on warfarin dosing vary among different ethnic groups, especially in the Chinese population. The objective of this study was to recruit patients through a rigorous experimental design and to perform a comprehensive screen to identify gene polymorphisms that may influence warfarin dosing in northern Han Chinese patients with mechanical heart valve replacement. Consenting patients (n = 183) with a stable warfarin dose were included in this study. Ninety-six single nucleotide polymorphisms (SNPs) in 30 genes involved in warfarin pharmacological pathways were genotyped using the Illumina SNP GoldenGate Assay, and their associations with warfarin dosing were assessed using univariate regression analysis with post hoc comparison using least significant difference analysis. Multiple linear regression was performed by incorporating patients’ clinical and genetic data to create a new algorithm for warfarin dosing. From the 96 SNPs analyzed, VKORC1 rs9923231, CYP1A2 rs2069514, CYP3A4 rs28371759, and APOE rs7412 were associated with higher average warfarin maintenance doses, whereas CYP2C9 rs1057910, EPHX1 rs2260863, and CYP4F2 rs2189784 were associated with lower warfarin doses (P < 0.05). Multiple linear regression analysis could estimate 44.4% of warfarin dose variability consisting of, in decreasing order, VKORC1 rs9923231 (14.2%), CYP2C9∗3 (9.6%), body surface area (6.7%), CYP1A2 rs2069514 (3.7%), age (2.7%), CYP3A4 rs28371759 (2.5%), CYP4F2 rs2108622 (1.9%), APOE rs7412 (1.7%), and VKORC1 rs2884737 (1.4%). In the dosing algorithm we developed, we confirmed the strongest effects of VKORC1, CYP2C9 on warfarin dosing. In the limited sample set, we also found that novel genetic predictors (CYP1A2, CYP3A4, APOE, EPHX1, CYP4F2, and VKORC1 rs2884737) may be associated with warfarin dosing. Further validation is needed to assess our results in larger independent northern Chinese samples. Wolters Kluwer Health 2017-01-13 /pmc/articles/PMC5266160/ /pubmed/28079798 http://dx.doi.org/10.1097/MD.0000000000005658 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3500
Liu, Rui
Cao, Jian
Zhang, Qian
Shi, Xin-Miao
Pan, Xiao-Dong
Dong, Ran
Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
title Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
title_full Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
title_fullStr Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
title_full_unstemmed Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
title_short Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
title_sort clinical and genetic factors associated with warfarin maintenance dose in northern chinese patients with mechanical heart valve replacement
topic 3500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266160/
https://www.ncbi.nlm.nih.gov/pubmed/28079798
http://dx.doi.org/10.1097/MD.0000000000005658
work_keys_str_mv AT liurui clinicalandgeneticfactorsassociatedwithwarfarinmaintenancedoseinnorthernchinesepatientswithmechanicalheartvalvereplacement
AT caojian clinicalandgeneticfactorsassociatedwithwarfarinmaintenancedoseinnorthernchinesepatientswithmechanicalheartvalvereplacement
AT zhangqian clinicalandgeneticfactorsassociatedwithwarfarinmaintenancedoseinnorthernchinesepatientswithmechanicalheartvalvereplacement
AT shixinmiao clinicalandgeneticfactorsassociatedwithwarfarinmaintenancedoseinnorthernchinesepatientswithmechanicalheartvalvereplacement
AT panxiaodong clinicalandgeneticfactorsassociatedwithwarfarinmaintenancedoseinnorthernchinesepatientswithmechanicalheartvalvereplacement
AT dongran clinicalandgeneticfactorsassociatedwithwarfarinmaintenancedoseinnorthernchinesepatientswithmechanicalheartvalvereplacement